Our team

Imbio is lead by our experienced team of entrepreneurs, healthcare IT and medical imaging veterans. We love our work of bringing more personalized healthcare to physicians and patients.

Danny Cunagin

Danny Cunagin, Chief Executive Officer

Danny Cunagin is the Chairman of the Board at Imbio and brings invaluable operational and strategic experience to the management team. Previously, he was the Chief Executive Officer and Chairman of the Board of Steady State Imaging, LLC where he led the commmercialization of a recently invented MRI technology and guided the sale of the company to GE Healthcare in 2011.
From 2005 to 2008, Mr. Cunagin served as the President of Micro Dynamics and Logic Product Development, a product engineering and manufacturing company with over 400 employees and sales in excess of $90 million. Prior to the merger with Micro Dynamics, he was CEO, Chairman and majority owner of Logic Product Development. Under his guidance, Logic grew from startup into one of the largest fully integrated product development-consulting firms in the US with sales in excess of $45 million and more than 100 product development engineers located in several international locations. He is the author of two patents, was noted as one of “forty under 40” in 1999 by City Business and has a B.S.M.E. from the University of Kentucky. Away from work, Danny is an avid endurance athlete and a burgeoning yogi.

David Hannes

David Hannes, Chief Operating Officer

David Hannes is the Chief Operating Officer of Imbio, having joined in April, 2015. He brings nearly 20 years of experience across Commercial Operations, Business Development and Strategy in both Fortune 50 and start-up medical device business to the Imbio team. Prior to joining Imbio, Mr. Hannes was Vice President of Business Development for NeuWave Medical, a microwave ablation start-up based out of Madison, Wisconsin.
Mr. Hannes joined NeuWave in its second year of commercial sales and was a key member of the leadership team which built the company into the market leader in microwave ablation, including gaining broad acceptance across the nation’s Top 50 cancer centers. Mr. Hannes led NeuWave’s Business Development and Strategy, corporate contracting and Marketing during this rapid transition from start-up to growth business. Prior to Neuwave, Mr. Hannes spent more than 14 years at GE Healthcare across a variety of operational and commercial leadership positions including Corporate Purchasing, Commercial Operations, Finance, and Global Service P&L leadership. Early in his career, Mr. Hannes was a manager in Ford Motor’s Corporate Purchasing group where he built his global commercial, strategy and lean manufacturing/operations experience. Mr. Hannes has a B.S. in Business from The University of Dayton and an MBA from the University of Madison – Wisconsin.

Steve Kohlmyer

Steve Kohlmyer, Chief Technology Officer

Steve Kohlmyer is the Chief Technology Officer for Imbio. He brings 26 years of experience in medical imaging spanning academic research, product engineering, commercialization, and frontline sales. Previously, Mr. Kohlmyer During spent 14 years at GE Healthcare where he helped shape the PET/CT modality as a research manager and
commercial sales leader during a phase of rapid growth in clinical adoption and utilization. Before joining GE, Mr. Kohlmyer was part of the Imaging Research Laboratory at the University of Washington, where he was a key participant in the transition of PET technology from a research tool into a viable clinical modality. Throughout these experiences Mr. Kohlmyer has participated in every phase of translation from research to commercialization. He holds a B.S. and M.S. in physics from the University of Washington.

Troy D. Kopischke

Troy D. Kopischke, Executive Board Member

Troy Kopischke is an Executive Board Member of Imbio. Previously, he was the President and Chief Financial Officer for Steady State Imaging where he was instrumental in developing a commercialization strategy that helped guide the sale of the company to GE Healthcare in 2011. In addition, Mr. Kopischke has held executive level positions in the product development and electronic products industries including Senior Executive Vice President at Micro Dynamics and Logic Product Development from 2005 to 2008.
During his tenure at Micro Dynamics and Logic, his contribution was critical in creating the largest embedded computing module company in the world. From 1999 to 2005 he was the President and Chief Financial Officer of Logic Product Development where he orchestrated dynamic new growth areas of the company. He also served as the Director of Engineering for Logic Product Development from 1999 to 2000. Mr. Kopischke holds a B.S.E.E. in Electrical Engineering from the University of Minnesota and a B.A. in Physics and a B.A. in Engineering Science from Bethel College. He is the author of two patents and is the recipient of the Jack Kilby Award from Texas Instruments and the Partner of the Year award from Freescale Semiconductor. Mr. Kopischke sits on the Board of Directors of various charitable organizations and enjoys family time, travel and dabbling in French cooking.

Alnawaz Rehemtulla

Alnawaz Rehemtulla, Ph.D., Co-Founder and Advisor

Dr. Rehemtulla is an endowed Professor of Radiation Oncology at the University of Michigan School of Medicine and serves as an advisor to Imbio.  He is focused on the development of imaging biomarkers to improve the diagnosis and treatment of cancer patients.  The majority of cancer patients are treated in part with ionizing radiation and Dr. Rehemtulla is well known among clinical Radiation Oncology departments.
He has been instrumental  in the development of the voxel-based technology and is a co-inventor on the licensed patents from the University of Michigan. Dr. Rehemtulla has a 20-year history of developing products in the fields of cancer and cardiovascular disease.  He trained at the Scripps Research Institute in La Jolla, where he developed technologies for diagnostic use in cardiovascular diseases.  While at the Genetics Institute in Cambridge MA, he was involved in the development of protein therapeutics for Hemophilia A and B, both of which are in use clinically.

Brian D. Ross

Brian D. Ross, Ph.D., Co-Founder and Advisor

Dr. Ross is a Tenured Professor of Radiology and Biological Chemistry at the University of Michigan School of Medicine and serves as an advisor to Imbio.  Co-inventor on the patents licensed by Imbio, Dr. Ross has been active in the technology development and implementation involving numerous clinical trials including for example, in patients with brain tumors, primary breast cancer, metastatic prostate cancer to the bone, head and neck cancer, lymphoma and sarcomas.
Dr. Ross has over 150 peer-reviewed publications and is Co-Editor of the recently released textbook “Molecular Imaging: Principles and Practice” considered to be the definitive book in the field of molecular imaging. He was recently elected as a Fellow of the International Society for Magnetic Resonance in Medicine.  As a founding member of the Society for Molecular Imaging, he has served as the past Treasurer, President-Elect and President of the Society.  Dr. Ross has also served as a member of the Advisory Panel of the American College of Radiology Imaging Network (ACRIN) and is currently serving as a Scientific Advisory Board member for the Cambridge Research Institute.  He was also Co-Founder and President of Molecular Imaging Research, which was recently purchased in a cash acquisition by Charles River Lab.

Dr. Jeremy Friese

Dr. Jeremy Friese, Advisor

Dr. Friese is an interventional radiologist at Mayo Clinic in Rochester, Minnesota. His clinical and research focus includes minimally invasive vascular disease and cancer. He serves as Medical Director for New Ventures and Business Development in the Center for Individualized Medicine and as Associate Chair of Finance in the Department of Radiology.
He is past chair of Novation’s imaging council and currently sits on the cardiovascular council. Dr. Friese is co-founder of Evidentia Health (a seed-stage HIT company), an active angel investor, and board member for SV Biosystems, Inc. He earned an M.D. from Mayo Medical School and an M.B.A. from Harvard Business School where he collaborated with Professors Clay Christensen and Michael Porter.

Eduard Michel

Eduard Michel, M.D., Advisor

Dr. Eduard Michel co-founded Virtual Radiologic Corp in 2001 and served as the Company’s Chief Medical Officer until 2011. During this period Virtual Radiologic became the largest radiology practice in the country, employing over 400 physicians and providing radiology professional services to more than 2,700 hospitals in the U.S.
Previously, Dr. Michel served as Assistant Professor of Radiology at the University of Minnesota and attending Neuroradiologist at Hennepin County Medical Center and North Memorial Medical Center. Dr. Michel completed his education at the University of Minnesota, and his Radiology residency and Neuroradiology fellowship at the University of Minnesota Hospital. He has authored more than 60 scientific articles and presented more than 45 scientific seminars at medical conferences around the world.